DOK2 Antikörper
-
- Target Alle DOK2 Antikörper anzeigen
- DOK2
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser DOK2 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunofluorescence (IF), Flow Cytometry (FACS)
- Produktmerkmale
- Homo sapiens docking protein 2, 56 kDa (DOK2)
- Aufreinigung
- Purified from mouse ascites fluids by affinity chromatography
- Immunogen
- Full length human recombinant protein of human DOK2(NP_003965) produced in HEK293T cell.
- Klon
- 2A3
- Isotyp
- IgG2a
- Top Product
- Discover our top product DOK2 Primärantikörper
-
-
- Applikationshinweise
- WB 1:2000, IF 1:100, FLOW 1:100,
- Kommentare
-
The concentration of the product may vary between diferrent lots.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.5-1.0 mg/mL
- Buffer
- PBS (PH 7.3) containing 1 % BSA, 50 % glycerol and 0.02 % sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
-
- Target
- DOK2
- Andere Bezeichnung
- DOK2 (DOK2 Produkte)
- Hintergrund
- The protein encoded by this gene is constitutively tyrosine phosphorylated in hematopoietic progenitors isolated from chronic myelogenous leukemia (CML) patients in the chronic phase. It may be a critical substrate for p210(bcr/abl), a chimeric protein whose presence is associated with CML. This encoded protein binds p120 (RasGAP) from CML cells.
- Molekulargewicht
- 45.2 kDa
- Gen-ID
- 9046
- NCBI Accession
- NM_003974
- HGNC
- 9046
-